Navigation Links
Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
Date:10/16/2008

First Synthetic Nanotechnology Implant Offers Promising Patient Solutions

MARQUETTE, Mich., Oct. 16 /PRNewswire/ -- Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the successful human implantation of its new biologic inter-body spacer. The nanOss(TM)- Cervical cage is machined from mechanically robust nano-crystalline hydroxyapatite (HA) and is designed to function as bone. The surgeries were performed at hospitals in Beijing and Suzhou, China, on patients indicated for standard cervical fusion surgery using the nanOss(TM)-Cervical implant, bone graft material, and anterior cervical plate.

Dr. Hansen Yuan, Professor of Orthopaedic and Neurological Surgery, State University of New York Upstate Medical University, Syracuse, NY performed the surgeries with Chinese surgeons and says, "The nanOss-Cervical cage was handled and implanted similarly to PEEK (poly-ether-ether-ketone) cages, and was used in conjunction with routine rigid fixation. The benefit of nanOss technology to the patient is it is a safe, natural substance and is biocompatible."

Pioneer's nanOss-Cervical cage is intended to facilitate spinal fusion procedures, by simultaneously maintaining decompression and serving as a graft containment device in conjunction with traditional rigid fixation.

Pioneer's CEO and Chairman of the Board, Dr. Matthew N. Songer says, "The hydroxyapatite nanOss-Cervical design is the frontier of the new generation of biologic implants that will replace the foreign materials that are currently used to reconstruct the spine."

In less than a year from acquiring the nanOss technology, Pioneer's development teams have created the nanOss-Cervical cage for fusion procedures. Strength properties of materials made of nanOss technology are twice as strong as PEEK cages yet, being biologic, behave as if it were bone.

About Pioneer Surgical Technology

Pioneer(R) Surgical Technology, Inc. is a dyn
'/>"/>

SOURCE Pioneer Surgical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler
2. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
3. Pioneer(R) Surgical Technology, Inc. Announces the Market Launch of the SlimFuse(TM) Anterior Cervical Plate System
4. Pioneer(R) Brand Soybeans From DuPont Deliver Step-Change in Soybean Yields
5. Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device
6. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
7. CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure
8. Reliant Technologies Announces FDA 510(K) Clearance of New Handpieces for Skin Resurfacing and Surgical Applications
9. New Opportunities in X-Ray Based Surgical Navigation With Ziehm NaviPort 3D
10. Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
11. Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Washington , July 30, 2015 ... Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial ... Discovery & Development, Preclinical, Clinical Trial), by End Users ... Biosimulation Market is expected to reach USD 2,107.99 million ... a CAGR of 15.29%. Browse more ...
(Date:7/30/2015)... , July 30, 2015   Aratana ... pet therapeutics company focused on the licensing, development ... animals, today announced that its strategic partner VetStem ... dose confirmation study of AT-016, an adipose-derived allogeneic ... the treatment of osteoarthritis pain in dogs. ...
(Date:7/30/2015)... 2015  With over 60,000 customers across the globe, ISN improves the efficiency and ... with more than 60,000 safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers ... Headquartered in Dallas, TX , ISN has ...
(Date:7/30/2015)... HIGHLIGHTS:Q2 2015 Results (all changes ... Reported sales were $697 million compared to $701 million ... by 8%, and changes in foreign currency exchange rates ... 1%. , By business unit, organic sales growth ... in SAFC Commercial. , Reported diluted EPS was ...
Breaking Biology Technology:Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... Premier Research Group plc, the,international pharmaceutical services ... buyout. As a result, the company is no,longer ... Stock Exchange. The UK-based,private equity firm ECI Partners ... Simon Yaxley, Chief Executive Officer of Premier Research,Group, ...
... Inc. (OTC,Bulletin Board: AGGX.OB) a New York-based biotechnology ... targeted anti-angiogenic drugs, announced the,appointment of William Garland ... Hoffmann La Roche, Inc., has directed research and,development ... companies such as,Centaur Pharmaceuticals, Atairgin Technologies, Lpath Therapeutics, ...
... 10 Spine surgeons at Pine Creek Medical,Center ... of a,cutting-edge surgical procedure that utilizes a patient,s ... Douglas Won, Michael Rimlawi, and Francisco J. Battle, ... stem cells,during routine spinal procedures and delivering those ...
Cached Biology Technology:Premier Research Announces Completion of Management Buyout 2AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 2AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 3Spine Surgeons at Pine Creek Medical Center Take the Lead in Utilizing Stem Cell Technologies in Surgical Procedures 2
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
(Date:7/2/2015)... June 25, 2015 ... addition of the "Natural Language Processing Market ... IVR, OCR, Pattern & Image Recognition) - Worldwide ... The key vendors occupying the market ... Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute Inc., ...
(Date:6/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ... America Biomedical Sensors Market - Growth, Trends & Forecasts ... Latin America Biomedical Sensors market is estimated at $0.65 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2
... enzyme viewed as an executioner, because it can push cells ... of cell death, researchers at Emory University School of Medicine ... by leading scientists to rethink how proposed anti-cancer and anti-inflammatory ... to work. The results are described in this week,s ...
... may be behind a progressively earlier bloom of a crucial ... the entire food chain and carbon cycling in the region. ... Diego, along with colleagues in Portugal and Mexico, plotted the ... the ocean food chainin the Arctic Ocean and found the ...
... WEST LAFAYETTE, Ind. - A Purdue University scientist ... of improved plant growth regulators that are expected to ... professor of horticulture, said the growth inhibitors block the ... throughout the plant, controls growth processes. Current growth regulators ...
Cached Biology News:Jekyll and Hyde: Cells' executioner can also stave off death 2Scripps oceanography researchers discover arctic blooms occurring earlier 2New growth inhibitors more effective in plants, less toxic to people 2
... Features, Special optically clear polystyrene formulation ... performance in immunoassay applications , Plates ... lower coefficients of variation , Eight-well ... elimi-nating strip loss while in use even ...
...
... Easy-Titer Human IgM Assay Kit to address ... easy-to-perform assay for Human IgM that eliminates ... incorporates a simple mix-and-read assay that allows ... 15-500 ng/ml in approximately 30 minutes. The ...
... clarification reagent; Ideal for clarifying many ... proteins, nucleic acids, & proteoglycans; Contains ... improves downstream processing; Utilizes a reagent ... supplied as a suspension in saline; ...
Biology Products: